Stocks · News reference
UnitedHealth rose after Q3 earnings and sales beat estimates; BIO-Key led gainers, while HUB Cyber Security topped premarket losers.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
J-Star Holding Co., Ltd. issued a clarification regarding the status of its 1-for-10 share consolidation, which was approved by shareholders at an Extraordinary General Meeting on October 29, 2026.
Fitness Champs Holdings Limited has filed to offer up to 14 million units of its securities.
The Schwab U.S. Dividend Equity ETF (SCHD) is highlighted as a strong buy-and-hold investment with a 15-year annualized return of 13.11%. The article suggests that $100 monthly investments could grow to $359,492 over 30 years. SCHD offers diversification away from AI stocks with holdings in energy, healthcare, and consumer staples sectors, making it potentially attractive for investors concerned about tech stock volatility.
Syndax Pharmaceuticals has received notification that 19 abstracts regarding its pipeline therapies, Revuforj and Niktimvo, have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting.
Syndax Pharmaceuticals announced the grant of stock options to five new employees as an inducement for their employment.
Syndax Pharmaceuticals will host an in-person investor event and live webcast on December 14, 2026, during the ASH Annual Meeting.